Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
This translation is provided for general access and has no recorded medical-language review.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
Pores, pigment, dryness, surface lines, elasticity and tissue laxity are not one clinical target. Published tightening evidence for HIFU does not show correction of every skin-quality concern; the goal, measurement method and alternatives should be defined separately before treatment.
This translation has no recorded clinical or medical-language review.
The surface, epidermal pigment, dermal structure, fat compartments and deeper supports create different concerns. Fine lines or dryness may be distinct from true laxity on examination. The device's authorized area and focal depth need to match the stated target. A broad rejuvenation label should not hide these differences or replace diagnosis and personal suitability assessment.
Laxity may require standardized photography and a validated grade; elasticity may require a suitable instrument; pigment may need colour measurement or clinical assessment. These outcomes are not interchangeable. Early swelling, lighting, makeup and expression can change appearance. A Global Aesthetic Improvement Scale is broad and cannot identify which tissue component changed.
Marked volume loss, dynamic muscle activity, pigment, active skin disease or advanced laxity may call for another approach or no procedure. If several interventions are planned, document sequence and the evidence limit of each. Possible benefit for one target is not a promise to improve all skin quality; follow-up should remeasure the specific baseline goal.
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
These links are editorial starting points used to examine the article's boundaries.
Contini M, Hollander MHJ, Vissink A, Schepers RH, Jansma J, Schortinghuis J · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Ling J, Zhao H · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Riopelle AM, Geisler AN, Eber A, Dover JS · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Niu Z et al. · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Foppiani JA et al. · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Austin GK, Struble SL, Quatela VC · 2022
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Sanyal RD, Fabi SG · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Prospective study authors · 2012
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review